trial · primary record
Ferumoxytol
Multiple Sclerosis
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2019-01-29 |
| Primary endpoint | change in gradient-echo T2*-weighted signal in an iron-rich brain structure, the globus pallidus |
| Registry ID | NCT02511028 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:59:02.352Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02511028
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ferumoxytol · approval
- Ferumoxytol · compound